David E. Sveen - 13 Jun 2023 Form 4 Insider Report for HESKA CORP

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Jun 2023, 18:27:50 UTC
Prior SEC filing
06 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ By: Catherine Grassman For: David E. Sveen

Key filing fact

David E. Sveen filed Form 4 for HESKA CORP on 14 Jun 2023.

Key facts

  • This page summarizes David E. Sveen's Form 4 filing for HESKA CORP.
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Jun 2023, 18:27.

Change

  • Previous filing in this sequence was filed on 06 May 2022.
  • Current net transaction value: -$5,169,720.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSKA transaction

Common Stock

Disposed to Issuer

Transaction value
$2,598,360
Shares
-21,653
Change %
-100%
Price
$120.00
Shares after
0
Date
13 Jun 2023
Ownership
Direct
Footnotes
F1
HSKA transaction

Common Stock

Disposed to Issuer

Transaction value
$1,714,200
Shares
-14,285
Change %
-100%
Price
$120.00
Shares after
0
Date
13 Jun 2023
Ownership
by Bethany Creek
Footnotes
F1, F2
HSKA transaction

Common Stock

Disposed to Issuer

Transaction value
$857,160
Shares
-7,143
Change %
-100%
Price
$120.00
Shares after
0
Date
13 Jun 2023
Ownership
by Lindberg Capital
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

David E. Sveen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer on the effective date of the merger.

Footnote F2

Represents shares held by Bethany Creek Partners, LP. Dr. Sveen is a general partner of and an investor in Bethany Creek Partners, LP.

Footnote F3

Represents shares held by Lindberg Capital Partners, LP. Dr. Sveen is a general partner of and an investor in Lindberg Capital Partners, LP.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .